SCHEMBL7733972

SCHEMBL7733972

COc1cc([N+](=O)[O-])ccc1N1CCN(CCCl)CC1

nearest known ligand 0.60

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.60
LMNA P02545 5/20 0.60
MAPT P10636 3/20 0.60
MAPK1 P28482 2/20 0.60
SMN1; SMN2 Q16637 2/20 0.60
HTR1A P08908 3/20 0.54
GAA P10253 1/20 0.53
DRD2 P14416 2/20 0.52
HTR2A P28223 2/20 0.52
KDM4E B2RXH2 1/20 0.50
ADRA1D P25100 2/20 0.49
ADRA1A P35348 2/20 0.49
ADRA1B P35368 2/20 0.49
HTT P42858 1/20 0.48
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
GFER P55789 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12040648 0.90 ALDH1A1 (0.57) ALDH1A1LMNAMAPTMAPK1SMN1; SMN2
SCHEMBL25797045 0.88 ALDH1A1 (0.57) ALDH1A1LMNAMAPTMAPK1SMN1; SMN2
SCHEMBL7732089 0.88 ALDH1A1 (0.60) ALDH1A1LMNAMAPTMAPK1SMN1; SMN2
SCHEMBL3176190 0.86 ALDH1A1 (0.67) ALDH1A1LMNAMAPTMAPK1SMN1; SMN2
SCHEMBL29556577 0.84 ALDH1A1 (0.64) ALDH1A1LMNAMAPTMAPK1SMN1; SMN2
SCHEMBL2062270 0.84 ALDH1A1 (0.64) ALDH1A1LMNAMAPTMAPK1SMN1; SMN2
SCHEMBL3957309 0.83 ALDH1A1 (0.70) ALDH1A1LMNAMAPTMAPK1SMN1; SMN2
SCHEMBL20591963 0.83 ALDH1A1 (0.57) ALDH1A1LMNAMAPTMAPK1SMN1; SMN2
SCHEMBL15540034 0.83 DRD2 (0.52) ALDH1A1LMNAMAPTMAPK1SMN1; SMN2
SCHEMBL25796957 0.82 ALDH1A1 (0.56) ALDH1A1LMNAMAPTMAPK1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6399614-B1 TREATING NEUROMUSCULAR DYSFUNCTION OF LOWER URINARY TRACT VIA PERIPHERAL OR CENTRAL NERVOUS SYSTEM; SEROTONIN RECEPTOR ANTAGONIST RECORDATI S.A. CHEMICAL AND PHARMACEUTICAL COMPANY (CH) 2002-06-04 US disclosed